Assessment of Erythropoiesis-Stimulating Agents for Anemia Treatment among Chronic Kidney Disease Patients: A Descriptive, Retrospective Study
Background: Renal anemia is a cause of significant morbidity, and to lesser extent mortality in patients with chronic kidney disease (CKD), the leading causes of anemia in CKD primarily are the lack of erythropoietin (EPO) and iron. Thus, effective management is possible using oral and intravenous (...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Zibeline International
2021-01-01
|
Series: | Matrix Science Medica |
Subjects: | |
Online Access: | http://www.matrixscimed.org/article.asp?issn=2521-0807;year=2021;volume=5;issue=1;spage=21;epage=24;aulast=Elamin |